Evidence map›Paper›PMID 32704017›Full record

ArticleScientific reports2020

A robust and miniaturized screening platform to study natural products affecting metabolism and survival in Caenorhabditis elegans.

Julia Zwirchmayr, Benjamin Kirchweger, Theresa Lehner, Ammar Tahir, Dagmar Pretsch, Judith M Rollinger

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
2.4field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 31 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Miquelianin and spiraeoside fromFrontiers in pharmacology · 2025
    Article
  6. Natural Compounds with Antifungal Properties againstAntibiotics (Basel, Switzerland) · 2023
    Article
  7. Article
  8. Antifungal Properties of Hydrazine-Based Compounds againstAntibiotics (Basel, Switzerland) · 2023
    Article
  9. Article
  10. Review
  11. Application ofInternational journal of molecular sciences · 2023
    Review
  12. Article
  13. Article
  14. Article
  15. Effect of DMSO on lifespan and physiology inmicroPublication biology · 2022
    Article
  16. Azepine-Indole Alkaloids FromFrontiers in neuroscience · 2022
    Article
  17. Fruit ofAntioxidants (Basel, Switzerland) · 2021
    Article
  18. Review
  19. Biomolecules · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Julia Zwirchmayr *Department of Pharmacognosy, Faculty of Life Sciences, University of Vienna, Althanstraße 14, 1090, Vienna, Austria.
Benjamin Kirchweger *Department of Pharmacognosy, Faculty of Life Sciences, University of Vienna, Althanstraße 14, 1090, Vienna, Austria.
Theresa LehnerDepartment of Pharmacognosy, Faculty of Life Sciences, University of Vienna, Althanstraße 14, 1090, Vienna, Austria.
Ammar TahirDepartment of Pharmacognosy, Faculty of Life Sciences, University of Vienna, Althanstraße 14, 1090, Vienna, Austria.
Dagmar PretschDepartment of Pharmacognosy, Faculty of Life Sciences, University of Vienna, Althanstraße 14, 1090, Vienna, Austria.
Judith M RollingerDepartment of Pharmacognosy, Faculty of Life Sciences, University of Vienna, Althanstraße 14, 1090, Vienna, Austria. judith.rollinger@univie.ac.at.
University of Vienna · AT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In this study a robust, whole organism screening based on Caenorhabditis elegans is presented for the discovery of natural products (NP) with beneficial effects against obesity and age-related diseases. Several parameters of the elaborated workflow were optimized to be adapted for probing multicomponent mixtures combining knowledge from traditional medicine and NP chemistry by generating optimized small-scale extracts considering scarcity of the natural source, solubility issues, and potential assay interferences. The established miniaturized assay protocol allows for in vivo probing of small amounts of even complex samples (~ 1 mg) to test their ability to increase the nematodes' survival time and the suppression of fat accumulation assessed by Nile red staining as hall marks of "healthy aging". The workflow was applied on 24 herbal and fungal materials traditionally used against symptoms of the metabolic syndrome and revealed promising results for the extracts of Gardenia jasminoides fruits and the sclerotia from Inonotus obliquus. Tested at 100 µg/mL they were able to significantly reduce the Nile red fluorescence and extend the 50% survival rate (DT

Indexed as

Mass ScreeningMiniaturizationAgaricalesAnimalsBiological AssayBiological ProductsCaenorhabditis elegansDimethyl SulfoxidePhenotypePlant ExtractsSurvival AnalysisBiological ProductsDimethyl SulfoxidePlant Extracts

Identifiers

PMID32704017
PMCPMC7378205
OpenAlexW3044637940

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.